Goldman Sachs Healthcare Stocks: Top 10 Stock Picks
The healthcare sector, long seen as a laggard amid the artificial intelligence boom, is beginning to turn the corner.
Abbvie Inc. (ABBV)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 2,033,800 | $464,702,962 | -16% | 0.07% | |
| 2. | GLG Partners Noam Gottesman | 1,808,707 | $413,271,463 | +41% | 0.7% |
| 3. | Adage Capital Management Phill Gross And Robert Atchinson | 1,508,715 | $344,726,290 | -19% | 0.52% |
| 4. | 1,432,800 | $327,380,472 | -25% | 0.05% | |
| 5. | AQR Capital Management Cliff Asness | 1,150,746 | $262,933,724 | +25% | 0.14% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $69.00 | 1,550 | $106,950.00 | 17,644 | 2020-03-20 | Filing | |
| $69.00 | 750 | $51,750.00 | 16,844 | 2020-03-20 | Filing | |
| $67.50 | 800 | $54,000.00 | 16,094 | 2020-03-20 | Filing | |
| $68.18 | 2,200 | $150,004.80 | 15,294 | 2020-03-18 | Filing | |
| $69.00 | 750 | $51,750.00 | 16,844 | 2020-03-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $233.56 | 5,230 | $1,221,518.80 | 2,654 | 2026-03-04 | Filing | |
| $235.26 | 2,600 | $611,676.00 | 4,619 | 2026-03-02 | Filing | |
| $234.66 | 10,291 | $2,414,886.06 | 7,219 | 2026-03-02 | Filing | |
| $233.51 | 5,777 | $1,348,987.27 | 17,510 | 2026-03-02 | Filing | |
| $230.00 | 22,381 | $5,147,630.00 | 38,137 | 2026-02-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 180,779,699 | $41,306,353,424 | 0.6% | |
| 2. | 151,174,543 | $34,541,871,411 | 0.58% | |
| 3. | 80,940,931 | $18,494,193,324 | 0.62% | |
| 4. | 52,393,323 | $11,971,351,030 | 0.75% | |
| 5. | 44,629,980 | $10,179,098,610 | 0.63% |
News See All
Is AbbVie Inc. (ABBV) One of the Debt Free Halal Stocks to Buy?
AbbVie Inc. (NYSE:ABBV) is one of the debt free halal stocks to buy. On March 3, at the TD Cowen 46th Annual Health Care Conference, AbbVie Inc.
11 Debt Free Halal Stocks to Buy
Jitters in the US equity market are rising as concerns about artificial intelligence, a looming software-as-a-service downturn, and ongoing conflict in the Middle East unsettled investors.
RBC Capital Says AbbVie Inc. (ABBV) Growth Story Is Still in Early Stages
On February 24, RBC Capital began coverage of AbbVie Inc. (NYSE:ABBV) with an Outperform rating and a price target of $260.
AbbVie Reports Promising Results from Phase 1 Study of ABBV-295
On March 9, AbbVie Inc. (NYSE:ABBV) reported encouraging results from a phase 1 study of its ABBV-295 drug, a long-acting amylin analog for treating obesity.
13 Undervalued Dividend Aristocrats to Buy Now
Dividend strategies remain popular for several reasons. A big part of the appeal is the steady income they can provide.
Starter Stock Portfolio: 14 Safe Stocks to Buy Now
Global stock markets have continued to struggle as oil prices surged to their highest weekly spike in six years, with no signs of an imminent end to the Middle East conflict.
12 Best Undervalued Stocks to Invest In Right Now
On March 3, Katie Stockton, Fairlead Strategies founder, appeared on CNBC’s ‘The Exchange’ to talk about her view on the equity markets, and more.
Is AbbVie Inc. (ABBV) One of the Best Cancer Stocks to Invest In Now?
AbbVie (NYSE:ABBV) is one of the best cancer stocks to invest in now.
Hedge Fund Resource Center